Highly-flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective preclinical target validation services, process development and scale-up production of biopharmaceuticals for research purposes or Phase I/II clinical trials.
Download our services overview (200KB .pdf) »
Commitment
Guided by our mission to provide exceptional quality, scientific excellence and superior customer service, Paragon is committed to;
- forging long-lasting partnerships and working relationships
- honoring delivery schedules and
- enhancing our client’s return on investment (ROI).
Focus
Paragon has built its service offering around the client’s need to validate a biopharmaceutical drug target and to ultimately produce batch sizes of material suitable for research purposes or Phase I/II clinical trials. By maintaining our focus on this market, Paragon offers cost-effective outsourcing services.
Partnership
Paragon’s team approaches each project with the understanding that every client’s research and manufacturing goals are unique. Our clients benefit from direct interaction with those responsible for the day-to-day management of their projects – knowledgeable and professional individuals empowered to make decisions to move your project forward swiftly. Strict confidentiality, periodic updates, clearly-presented information, effective project management and timely delivery are hallmarks of our service.
Quality Assurance
As a provider of contract research and manufacturing services for Phase I /II clinical trials, Paragon is both Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP) compliant and provides batch records, quality control analysis, and certificates of analysis.
Market Sense
Paragon understands the need to get a product to market quickly and economically. We work hard to gain insight into the potential product in development and to define appropriate methods to achieve project goals. At the same time, Paragon owns no proprietary expression systems or patented purification processes which could expose clients to long-term licensing issues.
Range
Paragon’s multidisciplinary team of scientists have extensive experience in applied research, process engineering and biopharmaceutical development. Recombinant proteins are produced via microbial, insect, or mammalian expression systems. Recombinant virus manufacturing offerings include adenovirus, AAV, lentivirus, and bacteriophage. Through work with our clients, the Paragon team is actively involved in some of the most challenging and promising areas including therapeutic proteins, vaccines candidates, monoclonal antibodies, and diagnostics including disease biomarkers.